Cargando…
Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers
Amit Sud speaks to Sebastian Dennis-Beron, Commissioning Editor: Amit Sud is a clinical research fellow in Hematology at the Institute of Cancer Research, UK. He undertook his undergraduate medical training at the University of Manchester, gaining an honors degree. He completed his Masters in Medica...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985503/ https://www.ncbi.nlm.nih.gov/pubmed/29881540 http://dx.doi.org/10.2217/ijh-2017-0008 |
_version_ | 1783328769376780288 |
---|---|
author | Sud, Amit |
author_facet | Sud, Amit |
author_sort | Sud, Amit |
collection | PubMed |
description | Amit Sud speaks to Sebastian Dennis-Beron, Commissioning Editor: Amit Sud is a clinical research fellow in Hematology at the Institute of Cancer Research, UK. He undertook his undergraduate medical training at the University of Manchester, gaining an honors degree. He completed his Masters in Medical Research at Manchester University, gaining a distinction. He continued his medical training in Manchester and London and started his specialization in Hematology in South West London. He was successful in obtaining a Cancer Research UK funded clinical research fellowship in Hematology under the supervision of Professor Richard Houlston at the Institute of Cancer Research. His current research focus is that of genetic susceptibility to Hodgkin lymphoma. He is a trainee member of the NCRI Lymphoma Clinical Studies Group. |
format | Online Article Text |
id | pubmed-5985503 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Future Medicine Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-59855032018-06-05 Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers Sud, Amit Int J Hematol Oncol Interview Amit Sud speaks to Sebastian Dennis-Beron, Commissioning Editor: Amit Sud is a clinical research fellow in Hematology at the Institute of Cancer Research, UK. He undertook his undergraduate medical training at the University of Manchester, gaining an honors degree. He completed his Masters in Medical Research at Manchester University, gaining a distinction. He continued his medical training in Manchester and London and started his specialization in Hematology in South West London. He was successful in obtaining a Cancer Research UK funded clinical research fellowship in Hematology under the supervision of Professor Richard Houlston at the Institute of Cancer Research. His current research focus is that of genetic susceptibility to Hodgkin lymphoma. He is a trainee member of the NCRI Lymphoma Clinical Studies Group. Future Medicine Ltd 2017-06 2017-06-30 /pmc/articles/PMC5985503/ /pubmed/29881540 http://dx.doi.org/10.2217/ijh-2017-0008 Text en © 2017 Future Medicine Ltd |
spellingShingle | Interview Sud, Amit Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers |
title | Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers |
title_full | Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers |
title_fullStr | Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers |
title_full_unstemmed | Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers |
title_short | Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers |
title_sort | survivors at risk: hodgkin lymphoma survivors at high risk of second cancers |
topic | Interview |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985503/ https://www.ncbi.nlm.nih.gov/pubmed/29881540 http://dx.doi.org/10.2217/ijh-2017-0008 |
work_keys_str_mv | AT sudamit survivorsatriskhodgkinlymphomasurvivorsathighriskofsecondcancers |